Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Minnesota Epilepsy Group
Saint Paul, Minnesota, United States
- Ownership
- Private
- Employees
- ~91
- Development stage
- Other
01
Overview
Minnesota Epilepsy Group is a nationally recognized level 4 epilepsy center offering comprehensive, multidisciplinary care and advanced diagnostics for epilepsy. It routinely participates in clinical trials for antiepileptic medications and medical devices, and provides both medical and surgical treatment for patients of all ages.[1][2][3][5][12]
- Therapeutic areas
- Neurology
- Modalities
- DeviceSmall moleculeNon-pharmacological therapy
- Industry
- Academic Hospital/University/Research
02
Partnerships
Abbott NorthwesternUnited HospitalChildren’s MinnesotaAllina Health
Beyond the preview
Go deeper on Minnesota Epilepsy Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Minnesota Epilepsy Group.